Demethylzeylasteral alleviates myeloid leukemia through PERK/eIF2α/ATF4/CHOP-mediated cell apoptosis

Xue Li, Xianchao He, Leyan Zhang, Zhigang Li, Yuanyuan Liu · 2025

Read Demethylzeylasteral alleviates myeloid leukemia through PERK/eIF2α/ATF4/CHOP-mediated cell apoptosis by Xue Li, Xianchao He, Leyan Zhang, Zhigang Li, Yuanyuan Liu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12776217.txt.

Description

Xue Li, Xianchao He, Leyan Zhang, and a wider team wrote this research paper, published in 2025. It shows that a plant compound, demethylzeylasteral, can kill myeloid leukemia cells by overloading their protein-folding machinery until they self-destruct.

The compound comes from a traditional medicinal plant and had shown anti-tumor effects elsewhere. The team screened sixty-five related compounds, then treated leukemia cells with the winner. Treated cells stopped dividing and died in rising numbers. Gene readouts pointed at the cell's unfolded-protein alarm chain, running through the named signaling steps to a death switch. Blocking links in that chain blunted the drug, confirming the route. In mice carrying human leukemia grafts, the compound slowed the disease. The authors propose it as a lead for a cancer short on new drugs.

Catalog record

CREATORXue Li, Xianchao He, Leyan Zhang, Zhigang Li, Yuanyuan Liu
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE48 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12776217

Browse the full library · About the Tower of Babel